Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade N/A
- Symbol (THCA)
- Company Tuscan Holdings Corp. II
- Price $10.44
- Changes Percentage (0%)
- Change $10.44
- Day Low $10.44
- Day High $10.44
- Year High $10.44
Tuscan Holdings Corp. II does not have significant operations. It intends to merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the cannabis industry. The company was incorporated in 2019 and is based in New York, New York. Tuscan Holdings Corp. II operates as a subsidiary of Tuscan Holdings Acquisition II LLC.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/14/2022
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio 0
- Forward P/E Ratio 0
- P/E Growth 0
- Net Income $4.65 M
Income Statement
Quarterly
Annual
Latest News of THCA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Millions of Americans could lose out on more than $700 in healthcare benefits if Congress doesn't keep these tax credits
Vice President Kamala Harris and former President Donald Trump have differing economic plans, but the impact of the Affordable Care Act (ACA) is crucial. Enhanced subsidies have increased ACA enrollme...
By Business Insider | 1 day ago -
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
Investing in healthcare stocks like CRISPR Therapeutics and Hims & Hers Health could lead to significant returns. CRISPR's gene-editing technology is gaining FDA approval, while Hims & Hers' digital h...
By Yahoo! Finance | 1 day ago -
CVS is weighing a breakup. What does it mean for the big healthcare business?
CVS is considering breaking up its integrated healthcare business, with potential spin-offs of Aetna and Caremark. This move reflects challenges faced by the company, sparking investor interest and sk...
By Yahoo! Finance | 2 days ago